Genzyme Agrees to Sell Pharmaceuticals Business to International Chemical Investors Group (February 1, 2011)
Genzyme press release announcing the signing of an agreement to sell its Pharmaceutical Ingredients Business and Y&P's advisory role
Young & Partners Article on Improving Chemical Financing Markets in ICIS Chemical Business (December 10, 2010)
Y&P article describing what is driving the recovery of the debt financing market, but the storm clouds that are appearing
Arizona Chemical Deal Press Release (November 19, 2010)
Press release covering the completion of the Arizona Chemical transaction and Y&P’s role as advisor to American Securities
Tronox Reaches Settlement With Equity Committee – Young & Partners acts as financial advisor to the Equity Committee (November 3, 2010)
Tronox Equity Committee reaches settlement with debtor and debt holders with regard to the reorganization plan
Pharma Deals on a Diet (Pharmaceutical Executive November 2010)
Y&P annual life sciences review of Pharma and Biotech M&A and financial developments, highlighting an active M&A but smaller deal market
The Chemical Financing Market Remains Choppy Despite Improvements (ICIS Chemical Business August 2010)
High yield surges as market seeks yield, but equity and senior debt markets are anemic
China – Behind the Screen (Pharmaceutical Executive July 2010)
Editor-in-Chief interviews Peter Young who provides overview of the structure and dynamics of the Chinese pharmaceutical market
Global Chemical M&A Up Significantly in H1 2010 (ICIS Chemical Business July 2010)
Mr. Young outlines why the chemical M&A market has strengthened and discusses the trajectory going forward
Is the Financing Crises Over? (ICIS Chemical Business May 2010)
Article describes the recovery in the debt financing markets in 2009 and early 2010 for chemicals after the financial crisis
The Deal Sheet (Pharmaceutical Executive May 2010)
Look back at 2009 and the strong pharma M&A and financing market, with two mega mergers and an industry shielded from the crisis